Abstract
Contrast media (CM) are widely used substances that may lead to hypersensitivity reactions. Those adverse events can be classified as immediate reactions that occur within the first hour after administration of CM or delayed reactions that develop after more than one hour and during the following 7 days. The pathomechanisms for both types of reactions are still not fully clear. Only in a minority of cases with immediate reactions an IgE-mediated pathway has been shown. In most cases, different mechanisms lead to the release of histamine and other mediators, thus provoking the symptoms of anaphylaxis. These reactions may either occur immediately after CM-injection or delayed. Moreover, some of the delayed reactions seem to be mainly T-cell mediated. Antihistamines are used in the treatment of adverse reactions as well as in the prophylaxis for patients with a history of a hypersensitivity reaction. Although the clinical aspect of frequently occurring reactions like urticaria, and angioedema (type I-reactions and type I-like reactions) implicates a first line application for antihistamines, the clinical experience shows that some cases do not respond to these agents. Therefore, it seems likely that other mediators such as leukotrienes might be involved in mediating CM-induced reactions.
Keywords: Contrast media, hypersensitivity, immediate reactions, delayed reactions, treatment, prophylaxis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Histamine-Dependent and -Independent Hypersensitivity Reactions to Contrast Media: The Impact of Antihistamines
Volume: 5 Issue: 2
Author(s): Esther A. Coors and Ingrid Bohm
Affiliation:
Keywords: Contrast media, hypersensitivity, immediate reactions, delayed reactions, treatment, prophylaxis
Abstract: Contrast media (CM) are widely used substances that may lead to hypersensitivity reactions. Those adverse events can be classified as immediate reactions that occur within the first hour after administration of CM or delayed reactions that develop after more than one hour and during the following 7 days. The pathomechanisms for both types of reactions are still not fully clear. Only in a minority of cases with immediate reactions an IgE-mediated pathway has been shown. In most cases, different mechanisms lead to the release of histamine and other mediators, thus provoking the symptoms of anaphylaxis. These reactions may either occur immediately after CM-injection or delayed. Moreover, some of the delayed reactions seem to be mainly T-cell mediated. Antihistamines are used in the treatment of adverse reactions as well as in the prophylaxis for patients with a history of a hypersensitivity reaction. Although the clinical aspect of frequently occurring reactions like urticaria, and angioedema (type I-reactions and type I-like reactions) implicates a first line application for antihistamines, the clinical experience shows that some cases do not respond to these agents. Therefore, it seems likely that other mediators such as leukotrienes might be involved in mediating CM-induced reactions.
Export Options
About this article
Cite this article as:
Coors A. Esther and Bohm Ingrid, Histamine-Dependent and -Independent Hypersensitivity Reactions to Contrast Media: The Impact of Antihistamines, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2006; 5 (2) . https://dx.doi.org/10.2174/187152306776872505
DOI https://dx.doi.org/10.2174/187152306776872505 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antiangiogenic Function of Antithrombin is Dependent on its Conformational Variation: Implication for Other Serpins
Protein & Peptide Letters Aliskiren: A New Drug for an Old Problem
Cardiovascular & Hematological Agents in Medicinal Chemistry Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Protein & Peptide Letters The Forward Path for Biopharmaceuticals and Biosimilars: Emerging Options in the Selection of Host Cell Systems
Current Biotechnology Drug-Induced Aseptic Meningitis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Inflammation and Coagulation in Urticaria and Angioedema
Current Vascular Pharmacology Plastid Molecular Pharming II. Production of Biopharmaceuticals by Plastid Transformation
Mini-Reviews in Medicinal Chemistry Novel Drugs for Inflammatory Lung Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents An Update on the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions
Current Pharmaceutical Design Skin Tests in the Diagnosis of Drug Hypersensitivity Reactions
Current Pharmaceutical Design Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their Toxicity
Current Medicinal Chemistry Update on Medical and Surgical Management of Intracerebral Hemorrhage
Reviews on Recent Clinical Trials Pharmacogenomics in Aspirin Intolerance
Current Drug Metabolism Kawasaki Disease and Its Treatment – An Update
Current Rheumatology Reviews Parvalbumin as a Pleomorphic Protein
Current Protein & Peptide Science Hypertension in Older Patients
Current Hypertension Reviews What Does a Pediatrician Need to Know About Chronic Diarrhea?
Current Pediatric Reviews Glucose Blood Levels as a Therapeutic Target in Acute Ischaemic Stroke Setting
Current Topics in Medicinal Chemistry Antibodies Against Complement System in SLE and their Potential Diagnostic Utility
Current Rheumatology Reviews Editorial (Current and Emerging Pharmacological Therapies of Ischaemic Stroke)
CNS & Neurological Disorders - Drug Targets